All Stories

BMS pushes Fulcrum off its list of partners, scrapping MyoKardia heart muscle pact

BMS pushes Fulcrum off its list of partners, scrapping ...

Mar 5, 2025 0

Bristol Myers Squibb is levering Fulcrum Therapeutics out of its life. MyoKardia...

BioNTech's RNA malaria vaccine trial hit by FDA hold

BioNTech's RNA malaria vaccine trial hit by FDA hold

Mar 5, 2025 0

The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s ...

BioNTech’s RNA malaria vaccine trial hit by FDA hold

BioNTech’s RNA malaria vaccine trial hit by FDA hold

Mar 5, 2025 0

The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s ...

DOGE terminates leases for 30 FDA sites across 23 states

DOGE terminates leases for 30 FDA sites across 23 states

Mar 4, 2025 0

Under President Donald Trump’s administration, DOGE has reportedly terminated le...

Blackstone buys majority stake in CMIC, Japan's largest contract research organization

Blackstone buys majority stake in CMIC, Japan's largest...

Mar 4, 2025 0

Private equity giant Blackstone is going big on Japan, acquiring a majority stak...

FDA elevates endovascular recall as Philips pulls Tack implant from the market

FDA elevates endovascular recall as Philips pulls Tack ...

Mar 4, 2025 0

Philips is pulling from the market an implant designed to help repair the interi...

Blackstone buys majority stake in CMIC, Japan’s largest contract research organization

Blackstone buys majority stake in CMIC, Japan’s largest...

Mar 4, 2025 0

Private equity giant Blackstone is going big on Japan, acquiring a majority stak...

IQVIA launches digital tool for ordering lab tests and managing specimens

IQVIA launches digital tool for ordering lab tests and ...

Mar 4, 2025 0

Global contract research organization IQVIA is looking to simplify workflows for...

China bans sales of Illumina DNA sequencers as Trump escalates global tariffs

China bans sales of Illumina DNA sequencers as Trump es...

Mar 4, 2025 0

Illumina has been barred from exporting its DNA sequencers to China, which close...

Acelyrin doubles down on Alumis merger after deciding Concentra’s surprise offer 'not superior'

Acelyrin doubles down on Alumis merger after deciding C...

Mar 4, 2025 0

Acelyrin consulted with independent advisors and came to the conclusion that the...

Fierce Biotech Layoff Tracker 2025: Atara halves workforce; BMS axes 223 jobs

Fierce Biotech Layoff Tracker 2025: Atara halves workfo...

Mar 4, 2025 0

As always, if you know of layoffs occurring at a biotech, please reach out to th...

PepGen pauses UK arm of DMD trial that's already on hold in US

PepGen pauses UK arm of DMD trial that's already on hol...

Mar 4, 2025 0

While PepGen works to persuade the FDA to let it launch a phase 2 trial of its D...

Fierce Biotech Fundraising Tracker '25: Garuda grabs $50M series A; Callio launches with $187M

Fierce Biotech Fundraising Tracker '25: Garuda grabs $5...

Mar 4, 2025 0

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

UPDATE: Biohaven's bipolar candidate fails to improve mania in pivotal trial

UPDATE: Biohaven's bipolar candidate fails to improve m...

Mar 4, 2025 0

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a ...

Atara, reeling from FDA hold on Ebvallo, lays off half of workforce

Atara, reeling from FDA hold on Ebvallo, lays off half ...

Mar 4, 2025 0

Atara Biotherapeutics is halving its headcount as it navigates the fallout from ...

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies

VC firm Sofinnova brings in €1.2B over a year to fund u...

Mar 4, 2025 0

Up to 60 new life sciences companies are set to benefit from 1.2 billion euros (...

Biohaven's biopolar candidate fails to improve mania in pivotal trial

Biohaven's biopolar candidate fails to improve mania in...

Mar 4, 2025 0

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a ...

VC firm Sofinnova brings in €1.6B over a year to fund up to 60 life sciences companies

VC firm Sofinnova brings in €1.6B over a year to fund u...

Mar 4, 2025 0

Up to 60 new life sciences companies are set to benefit from 1.6 billion euros (...

Gene therapy prevents death, restores growth in mice and a calf with maple syrup urine disease

Gene therapy prevents death, restores growth in mice an...

Mar 4, 2025 0

A one-time injection of a novel gene therapy was able to save mice and a newborn...

VC firm Sofinnova brings in 1.6B euros over a year to fund up to 60 life sciences companies

VC firm Sofinnova brings in 1.6B euros over a year to f...

Mar 4, 2025 0

Up to 60 new life sciences companies are set to benefit from 1.6 billion euros (...

Biohaven’s biopolar candidate fails to improve mania in pivotal trial

Biohaven’s biopolar candidate fails to improve mania in...

Mar 4, 2025 0

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a ...

Novartis hands over $55M upfront to license preclinical hives prospect from Japan's Kyorin

Novartis hands over $55M upfront to license preclinical...

Mar 3, 2025 0

Deal-happy Novartis is further bolstering its preclinical pipeline and continuin...

Paragonix's donor kidney perfusion system completes commercial flight

Paragonix's donor kidney perfusion system completes com...

Mar 3, 2025 0

The KidneyVault is more than a simple ice chest. It pumps a cooled, specialized ...

Paragonix’s donor kidney perfusion system completes commercial flight

Paragonix’s donor kidney perfusion system completes com...

Mar 3, 2025 0

The KidneyVault is more than a simple ice chest. It pumps a cooled, specialized ...

16
17
18
19
20

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.